Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

GlobeNewsWire

17 Jun 2026, 13:52 UTC · 2h ago

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

What the story claims

3 claims · each scored for market impact

What matters in this story

1
The FDA clearance for TriSalus Life Sciences' TriNav Advance is delayed by approximately five months past the MDUFA review goal. — Regulatory delays for key medical devices directly hinder commercialization timelines and projected revenue growth.
-0.80
2
TriSalus Life Sciences has lowered its full-year revenue guidance following a year-over-year Q1 revenue decline of more than 2.9%. — A combination of declining current revenue and a downward revision of future expectations typically triggers a valuation haircut.
-0.60
3
The Schall Law Firm has launched a fraud investigation into TriSalus Life Sciences for potential violations of securities laws and misleading statements. — While common for law firms to announce investigations after a price drop, it introduces legal risk and potential litigation costs.
-0.40

Which stocks this story touches

6 related stories

GlobeNewsWire
2h ago
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
- class action
- fda
- fraud investigation
Read

TLSI Investors Have Oppor… — TLSI -1.00 | NewsImpactScreener

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

What matters in this story

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

What matters in this story

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm

How each ticker is affected

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)

Prediction: Marvell Stock Will Hit $300 On This Date

LyondellBasell: Wait While The Phoenix Rises From The Ashes (Rating Downgrade)

Can STMicroelectronics Turn Stronger Bookings Into Gross Margin Gains?

Ramaco Resources Inc. Secondary Public Offering Investors (NASDAQ: METC) May Be Eligible to Recover Losses

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

What matters in this story

Next reads from the same story arc

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

What matters in this story

Next reads from the same story arc

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm

How each ticker is affected

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)

Prediction: Marvell Stock Will Hit $300 On This Date

LyondellBasell: Wait While The Phoenix Rises From The Ashes (Rating Downgrade)

Can STMicroelectronics Turn Stronger Bookings Into Gross Margin Gains?

Ramaco Resources Inc. Secondary Public Offering Investors (NASDAQ: METC) May Be Eligible to Recover Losses